Antonia Dimitrakopoulou-Strauss
Overview
Explore the profile of Antonia Dimitrakopoulou-Strauss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sachpekidis C, Enqvist O, Ulen J, Kopp-Schneider A, Pan L, Mai E, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39984746
No abstract available.
2.
Schiza A, Nega A, Dimitrakopoulou-Strauss A, Gregoriou V, Chochos C
Macromol Rapid Commun
. 2025 Jan;
:e2400739.
PMID: 39887749
Novel amphiphilic π-conjugated polymer nanoparticles tailored to efficiently absorb in the near-infrared II (NIR-II) region of the electromagnetic spectrum (>1000 nm) are presented. To achieve this, it is statistically introduced...
3.
Vlachavas E, Voutetakis K, Kosmidou V, Tsikalakis S, Roditis S, Pateas K, et al.
Mol Oncol
. 2025 Jan;
PMID: 39876058
Colorectal cancer (CRC) patients with microsatellite-stable (MSS) tumors are mostly treated with chemotherapy. Clinical benefits of targeted therapies depend on mutational states and tumor location. Many tumors carry mutations in...
4.
Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770483
Molecular imaging is a growing field, driven by technological advances, such as the improvement of PET-CT scanners through the introduction of digital detectors and scanners with an extended field of...
5.
Sachpekidis C, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A
Semin Nucl Med
. 2024 Dec;
PMID: 39674756
[F]FDG PET/CT is a powerful imaging modality of high performance in multiple myeloma (MM) and is considered the appropriate method for assessing treatment response in this disease. On the other...
6.
Neelsen C, Sachpekidis C, John L, Neher P, Mai E, Grozinger M, et al.
Eur Radiol
. 2024 Nov;
PMID: 39604650
Objectives: This study aims to evaluate correlations between spleen signal changes in different MRI sequences and bone marrow plasma cell infiltration as potential indicator of disease burden in multiple myeloma...
7.
Glemser P, Freitag M, Kovacs B, Netzer N, Dimitrakopoulou-Strauss A, Haberkorn U, et al.
EJNMMI Rep
. 2024 Nov;
8(1):37.
PMID: 39510993
Background: To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in...
8.
Dimitrakopoulou-Strauss A, Sachpekidis C, Lapa C
Front Nucl Med
. 2024 Oct;
2:904502.
PMID: 39354967
No abstract available.
9.
Pan L, Sachpekidis C, Hassel J, Christopoulos P, Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging
. 2024 Sep;
52(2):623-637.
PMID: 39256215
Aim: The recently introduced Long-Axial-Field-of-View (LAFOV) PET-CT scanners allow for the first-time whole-body dynamic- and parametric imaging. Primary aim of this study was the comparison of direct and indirect Patlak...
10.
Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C
Semin Nucl Med
. 2024 Jun;
55(1):3-10.
PMID: 38851935
Recently developed long axial field of view (LAFOV) PET-CT scanners, including total body scanners, are already in use in a few centers worldwide. These systems have some major advantages over...